United Therapeutics | UTHR

Stock Price
220.66
Daily Change
0.19%
Yearly
-3.53%
Q2 Forecast
210.92
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Amarin 1.28 0.02 1.59% -32.28%
Ardelyx 3.76 0.03 0.80% 429.65%
Baxter International 42.14 1.18 2.88% -42.16%
Bayer 52.13 -0.15 -0.29% -20.86%
BioCryst Pharmaceuticals 8.81 0.28 3.28% -19.03%
Biogen 304.90 5.11 1.70% 47.49%
BioMarin Pharmaceutical 91.00 -1.01 -1.10% 17.31%
Emergent BioSolutions 8.50 0.49 6.12% -73.40%
Esperion Therapeutics 1.36 -0.01 -0.73% -77.70%
Gilead Sciences 76.08 -0.12 -0.16% 21.96%
GlaxoSmithKline 1,376.20 -15.20 -1.09% -21.40%
Halozyme Therapeutics 34.72 0.74 2.18% -24.85%
Intercept Pharmaceuticals 11.97 0.66 5.84% -14.19%
Insmed 19.78 0.32 1.64% -0.35%
Ionis Pharmaceuticals 40.55 -2.78 -6.42% 15.86%
Intra Cellular Therapies 65.13 -0.28 -0.43% 13.05%
J&J 158.52 0.34 0.21% -10.58%
Lexicon Pharmaceuticals 2.93 0.27 10.15% 63.69%
Moderna 125.61 -1.29 -1.02% -15.43%
Omeros 7.05 -0.03 -0.42% 223.39%
Pfizer 38.89 0.52 1.36% -27.27%
PTC Therapeutics 43.58 -1.44 -3.19% 54.87%
Regeneron Pharmaceuticals 738.63 -9.51 -1.27% 21.53%
Seattle Genetics 194.75 -0.72 -0.37% 34.97%
Sangamo BioSciences 1.30 0.04 3.17% -69.56%
Sarepta Therapeutics 127.90 -0.70 -0.54% 77.00%
Teva Pharmaceutical Industries 2,688.00 -23.00 -0.85% -9.49%
United Therapeutics 220.66 0.41 0.19% -3.53%
Vertex Pharmaceuticals 324.65 -5.76 -1.74% 18.25%

Indexes Price Day Year
USND 13105 -171.52 -1.29% 8.43%
US400 2569 38.37 1.52% 1.90%

United Therapeutics

United Therapeutics traded at $220.66 this Wednesday June 7th, increasing $0.41 or 0.19 percent since the previous trading session. Looking back, over the last four weeks, United Therapeutics gained 4.85 percent. Over the last 12 months, its price fell by 3.53 percent. Looking ahead, we forecast United Therapeutics to be priced at 210.92 by the end of this quarter and at 193.10 in one year, according to Trading Economics global macro models projections and analysts expectations.

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The Company market and sell four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution, which includes the Tyvaso Inhalation System; Orenitram (treprostinil) Extended-Release Tablets; and Adcirca (tadalafil) Tablets. In the United States, the Company also markets and sells an oncology product, Unituxin (dinutuximab) Injection, which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion.